Study: NCT05654467

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Novel Live Attenuated Type 3 Oral Poliomyelitis Vaccine (nOPV3)
Description: The nOPV3 vaccine containing approximately 10\^5.5, 10\^6.0, or 10\^6.5 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
Description: The Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 control and challenge vaccine (mOPV3) containing ≥ 10\^5.8 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
Description: The Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 control and challenge vaccine (mOPV3) containing ≥ 10\^5.8 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
Description: The Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 control and challenge vaccine (mOPV3) containing ≥ 10\^5.8 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
Description: The Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 control and challenge vaccine (mOPV3) containing ≥ 10\^5.8 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
Description: The Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 control and challenge vaccine (mOPV3) containing ≥ 10\^5.8 CCID50 per dose.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 (mOPV3)
Description: The Sabin Monovalent Oral Poliomyelitis Vaccine Type 3 control and challenge vaccine (mOPV3) containing ≥ 10\^5.8 CCID50 per dose.